tiprankstipranks
pc:bea3v

Beacon Therapeutics

14193 NW 119th Terrace Suite #10 Alachua, Florida 32615, US
https://www.beacontx.com/
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company develops gene therapies targeting blinding retinal diseases, including X-linked retinitis pigmentosa (laru-zova), geographic atrophy, and inherited cone-rod dystrophies.

Leadership & Board

Current Number of Employees96
Current LinkedIn Followers9,497

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$75M
Total Amount Raised$75M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$75M
Latest Funding Amount$75M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Employee Trend

Beacon Therapeutics had 96 employees as of April 6, 2026. The number of employees increased by 1 (1.05%) week-over-week.
96Latest Employee Count
1(1.05%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Beacon Therapeutics had 9,497 followers as of April 6, 2026. The number of followers increased by 34 (0.36%) week-over-week.
9,497Latest Followers Count
34(0.36%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series C
$75.00M

Related News and Analysis